CellEctric
The cell is at the center of current and future biological science. Future trends require novel technologies to unlock their full potential. The combination of electrodynamics and biotechnology perfectly complements the requirements of emerging industries when it comes to efficient analysis and manipulation of biological cells.
xista team
Selective and scalable technology platform
CellEctric is the next evolutionary step in mammalian cell manipulation. The technology allows the continuous processing of cell suspensions while selectively permeabilizing or disintegrating targeted subsets by electromagnetic manipulation. The competitive advantage is based on the exclusion of unspecific interference by a patented dielectric filter technology along the electrodes. It allows for pure electrodynamics without electrochemistry. This enables the high selectivity and specificity of our fully automated and customizable sample preparation platform.
Convincing first use cases
With rapid sepsis diagnosis as a first use case generating interest from several renowned diagnostic companies, the novel approach implemented by the founders Klemens Wassermann and Terje Wimberger allows for additional use cases including isolation of viable bacteria or leukocytes from whole blood, specific tumor cell disruption from complex samples, small molecule transfer in living cells and others.
Our investment rationale
Coming from a strong academic background with several high impact, peer reviewed publications, the founders demonstrated business acumen early on and developed a scalable technology platform in close collaboration with the industry, leading to a compelling beachhead market with significant expansion potential.